HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Tao Selected Research

ZY0511

6/2023Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
11/2021Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
10/2019ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
10/2019Corrigendum to "ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway" [Cancer Lett. 454 (2019) 179-190].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Tao Research Topics

Disease

77Neoplasms (Cancer)
05/2024 - 02/2002
29Squamous Cell Carcinoma of Head and Neck
04/2024 - 02/2002
24Carcinoma (Carcinomatosis)
07/2023 - 06/2004
11Neoplasm Metastasis (Metastasis)
09/2023 - 02/2002
10Lymphatic Metastasis
06/2022 - 09/2004
9Wounds and Injuries (Trauma)
04/2024 - 03/2015
9Inflammation (Inflammations)
01/2022 - 01/2011
7Carcinogenesis
05/2024 - 10/2013
7Laryngeal Neoplasms (Laryngeal Cancer)
02/2022 - 07/2006
7Breast Neoplasms (Breast Cancer)
10/2021 - 12/2009
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2020 - 02/2002
6Hemorrhage
11/2023 - 07/2009
5Hepatocellular Carcinoma (Hepatoma)
06/2023 - 12/2008
5Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 08/2013
4Rheumatoid Arthritis
05/2021 - 02/2016
4Esophageal Squamous Cell Carcinoma
03/2012 - 04/2010
3Melanoma (Melanoma, Malignant)
01/2023 - 05/2019
3Brain Ischemia (Cerebral Ischemia)
09/2019 - 01/2015
3Hyperthermia
03/2019 - 06/2017
3Leukoplakia
11/2016 - 12/2013
2Colitis
04/2024 - 01/2016
2Ulcerative Colitis
04/2024 - 11/2023
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2024 - 11/2023
2Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 10/2021
2Papillary Thyroid Cancer
01/2023 - 10/2020
2Atrophy
01/2023 - 01/2022
2Retinal Degeneration
01/2023 - 01/2023
2Macular Degeneration (Age-Related Maculopathy)
01/2023 - 01/2022
2Infections
12/2022 - 09/2022
2Stomach Neoplasms (Stomach Cancer)
10/2022 - 01/2017
2Multiple Sclerosis
08/2022 - 05/2021
2Lung Injury
01/2021 - 01/2020
2Chronic Renal Insufficiency
12/2020 - 01/2015
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2020 - 01/2018
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2020 - 09/2019
2Neuralgia (Stump Neuralgia)
01/2020 - 05/2016
2Hyperalgesia
01/2020 - 05/2016
2Reperfusion Injury
09/2019 - 01/2015
2Margins of Excision
08/2019 - 11/2018

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
04/2024 - 02/2002
10Biomarkers (Surrogate Marker)IBA
05/2024 - 06/2006
9HydrogelsIBA
04/2024 - 01/2013
8Messenger RNA (mRNA)IBA
10/2022 - 09/2004
6Dihydroorotate DehydrogenaseIBA
11/2023 - 01/2020
6EnzymesIBA
11/2023 - 10/2013
6RetinoidsIBA
01/2023 - 01/2015
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 10/2010
5Interleukin-10 (Interleukin 10)IBA
10/2019 - 12/2013
4ZY0511IBA
06/2023 - 10/2019
4ChitosanIBA
06/2022 - 12/2008
4CytokinesIBA
01/2022 - 05/2016
4FlavonoidsIBA
12/2019 - 07/2013
4Cisplatin (Platino)FDA LinkGeneric
11/2014 - 11/2005
3Indicators and Reagents (Reagents)IBA
04/2024 - 01/2019
3AntioxidantsIBA
04/2024 - 02/2016
3Dextran SulfateIBA
04/2024 - 01/2016
3PolymersIBA
12/2023 - 09/2020
3Therapeutic UsesIBA
11/2023 - 07/2020
3Retinaldehyde (Retinal)IBA
01/2023 - 01/2022
3Peptide Initiation Factors (Initiation Factor)IBA
01/2023 - 06/2004
3pyrimidineIBA
12/2022 - 05/2021
3Glucose (Dextrose)FDA LinkGeneric
10/2022 - 11/2013
3Drug CarriersIBA
02/2022 - 03/2015
3Chimeric Antigen ReceptorsIBA
09/2021 - 07/2020
3CateninsIBA
01/2021 - 03/2012
3LigandsIBA
07/2020 - 11/2010
3Caspase 3 (Caspase-3)IBA
03/2020 - 06/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
02/2016 - 10/2010
3Peroxidase (Myeloperoxidase)IBA
01/2016 - 02/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 06/2004
3Chemokine ReceptorsIBA
09/2013 - 09/2010
3gambogic acidIBA
10/2010 - 12/2009
3elemeneIBA
07/2006 - 06/2004
2Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 11/2014
2Ethanol (Ethyl Alcohol)IBA
01/2024 - 02/2022
2LipidsIBA
12/2023 - 11/2021
2purineIBA
07/2023 - 10/2021
2Lysine (L-Lysine)FDA Link
06/2023 - 10/2019
2teriflunomideIBA
08/2022 - 12/2021
2Hemostatics (Antihemorrhagics)IBA
06/2022 - 12/2016
2Serine (L-Serine)FDA Link
10/2021 - 01/2021
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2021 - 01/2015
2LipopolysaccharidesIBA
01/2021 - 10/2019
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 11/2013
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
09/2019 - 01/2017
2Neuroprotective AgentsIBA
09/2019 - 01/2015
2Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2019 - 01/2015

Therapy/Procedure

26Therapeutics
05/2024 - 08/2010
11Drug Therapy (Chemotherapy)
09/2023 - 11/2005
9Laryngectomy
08/2023 - 01/2018
8Radiotherapy
04/2024 - 01/2018
5Neck Dissection (Radical Neck Dissection)
01/2023 - 09/2008
4Chemoradiotherapy
01/2023 - 04/2010
4Lasers (Laser)
11/2022 - 08/2006
3Immunotherapy
08/2023 - 07/2020
3Intraperitoneal Injections
11/2013 - 11/2005
2Induction Chemotherapy
01/2023 - 01/2022
2Tracheotomy
05/2022 - 12/2021
2Cell- and Tissue-Based Therapy (Cell Therapy)
07/2020 - 07/2018
2Injections
03/2019 - 06/2017